
Myka Labs selected to present at leading investor conference
Myka Labs CEO Dan Laser, Ph.D. will join executives from other leading life sciences companies in presenting at the LSI Europe investor conference, taking place
Myka Labs CEO Dan Laser, Ph.D. will join executives from other leading life sciences companies in presenting at the LSI Europe investor conference, taking place
During the annual meeting of the American Society of Pediatric Surgery (APSA) held this week in Phoenix, Arizona, the organization bestowed its highest honor, the
While Connect is an incredible advance in the field of pediatric surgery, Myka’s pipeline of products based on its proprietary advanced sensor system architectures and artificial intelligence-based
Myka Labs announced today the addition of two key figures to its Clinical Advisory Board. Dr. Ivo Boskoski is Assistant Professor of Gastroenterology at the
Longtime Dana Farber Cancer Institute CEO Dr. Edward Benz and Dr. Richard Isaacs, former CEO of Kaiser Permanente, bring extraordinary breadth of knowledge and experience
Pancreatic Cancer Early Detection Consortium (PRECEDE) meeting brings together leading pancreatic cancer researchers from around the world in New York City Myka Labs, a San
CEOs of leading companies with products in pediatric and maternal health, including Dan Laser of Myka Labs, gathered at the Stanford Byers Center for Biodesign
A presentation by Myka Labs CEO Dan Laser will be one of a handful of company presentations that will be spotlighted during the upcoming 2023
Paper appears in the March 2024 issue of the Journal of Pediatric Surgery. A new publication appearing in a leading pediatric surgery journal concludes that
In a major presentation at a leading pediatric surgery meeting, Myka Labs revealed key details of the design and functionality of a family of innovative
Daniel Laser, Myka Labs CEO, will join a panel including other thought leaders in artificial intelligence speaking at a major conference to be held in
Groundbreaking research on new ways of treating complications of Crohn’s disease, being jointly conducted by researchers from Myka Labs, ISCARE and the University of California